Anthem Biosciences Ltd.

₹942.95

-14.8 (-1.6%)

ANTHEM Share Price

Pharmaceuticals & Biotechnology

As on September 9, 2026

SectorNA

IndustryPharmaceuticals & Biotechnology

Basic IndustryBiotechnology

Market Cap₹ 53,926 Cr

P/E Ratio90.91

Dividend Yield0.1 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	943.8	Bearish
10-DMA	929.58	Bullish
20-DMA	907.94	Bullish
50-DMA	838.29	Bullish
100-DMA	804.43	Bullish
200-DMA	730.57	Bullish

Historical Performance

1 Year

17.4%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	21,243	18,446	14,194	10,569	12,313
Total Expenditure	12,904	11,735	9,143	6,341	6,642
Other Income	1,558	857	637	850	490
Operating Profit	9,898	7,568	5,688	5,079	6,161
Interest	71	105	97	87	122
Depreciation	1,341	894	818	637	578
Profit Before Tax	8,242	6,569	4,773	4,973	5,461
Consolidated Net Profit	5,918	4,513	3,673	3,852	4,055
Adjusted EPS	11	8	7	7	7

Compounded Sales Growth

10 Years:47.1

5 Years:14

3 Years:15

TTM:2.9

Compounded Profit Growth

10 Years:63.9

5 Years:16.9

3 Years:9

TTM:5.6

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:15.7

Return on Equity

10 Years:0.7

5 Years:7.1

3 Years:6.6

last year:10.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	1,123	1,118	1,118	1,141	88
Total Reserves	28,968	22,637	18,128	16,266	13,462
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	337	535	934	850	217
Other Current Liabilities	1,879	1,463	1,073	536	1,094
Short Term Borrowings	44	430	1,209	289	296
Total Liabilities	36,060	29,486	24,767	21,045	17,259
Capital Work in Progress	2,643	2,969	3,447	1,641	1,538
Long Term Loans & Advances	504	291	346	467	223
Currents Investments	6,656	3,123	4,591	4,929	2,691
Short Term Loans and Advances	3,441	3,620	2,530	1,958	2,040
Total Current Assets	20,071	16,472	16,016	14,382	12,163
Total Assets	36,060	29,486	24,767	21,045	17,259
Adjusted Book Value	54	42	34	31	24

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 90.91, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 31.1%, indicating sustained price appreciation.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹9898 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹21243 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1156710

No. of Shares: 1227 (Approx)

Performance:15.7%

156710

NIFTY Performance: -6.2%

1 day Top Gainers